Does ALEMTUZUMAB Cause Dysgeusia? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Dysgeusia have been filed in association with ALEMTUZUMAB (Campath). This represents 0.9% of all adverse event reports for ALEMTUZUMAB.
129
Reports of Dysgeusia with ALEMTUZUMAB
0.9%
of all ALEMTUZUMAB reports
1
Deaths
32
Hospitalizations
How Dangerous Is Dysgeusia From ALEMTUZUMAB?
Of the 129 reports, 1 (0.8%) resulted in death, 32 (24.8%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Dysgeusia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Dysgeusia?
NIRMATRELVIR\RITONAVIR (7,381)
SUNITINIB MALATE (1,226)
SODIUM (1,216)
LENALIDOMIDE (1,180)
LIFITEGRAST (1,067)
CABOZANTINIB S-MALATE (777)
CLARITHROMYCIN (717)
VISMODEGIB (706)
ADALIMUMAB (674)
PALBOCICLIB (620)
Which ALEMTUZUMAB Alternatives Have Lower Dysgeusia Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET